Tuberculosis is an infectious bacterial disease characterized by the growth of tubercles (small nodular lesions which particularly form in the bone or other tissues) in the lung. There are two types of tuberculosis: latent and active. In the former, the infection does not exhibit any symptoms, whereas chronic cough with blood-containing sputum, fever, and night sweat are symptoms of the latter. Tuberculosis spreads through the medium of air. Active tuberculosis occurs more often in HIV/AIDS-affected people, with diagnosis commonly done through chest x-rays and through a microscopic examination of culture body fluids. Latent tuberculosis is detected through tuberculin skin tests or blood tests. Those in prolonged and close contact with tuberculosis-infected people are at a particularly high risk to be infected themselves. A person suffering active but untreated tuberculosis could infect ten to twelve person in a year. Tuberculosis occurs worldwide and has been identified as a major factor of death.

On the basis of test, the tuberculosis therapeutic market is segmented into the diagnostic laboratory and radiographic methods. Diagnostic laboratory tests hold the maximum market share as they are highly cost-effective and easy to perform compared to radiographic tests. However, compromised accuracy and longer processing time are the two factors limiting this segment. The health care industry is therefore seeking advanced techniques to overcome these problems. Macro-economic factors, environmental factors, and the rising smokers’ population drive the tuberculosis therapeutic market. Advancements in x-ray systems, especially through mobile radiography and portable equipment such as the Practix 400 Plus are propelling the tuberculosis therapy market. However, multiple & specific drug resistance and the dearth of efficient lab technicians act as major restraints. In some countries, BCG vaccines are administered right in the childhood in order to fight tuberculosis. The markets for both – the vaccines as well as equipment – expand on parallel tracks. The development of new vaccines such as MVA85A, Rbcg30, and 72F fusion proteins constitutes a major share in the tuberculosis therapeutic market. There is urgent need for the development of better diagnostics owing to the rising rate of anti-tuberculosis drugs.

Geographically North America and Latin America account for a prominent share in the tuberculosis therapeutic market because of the increasing awareness about the disease and its impact on human life. The higher use of BCG vaccination could further propel the market in the U.S. Europe follows the strategic guidelines provided by government bodies for its use of drugs against tuberculosis and vaccination schedules for children, which aids the expansion of the market. The tuberculosis situation in Asia Pacific, especially India, is highly critical. Every week, around ten thousand people succumb to death by tuberculosis. The revised national tuberculosis program in India plays a vital role in controlling this issue, with the growing population increasingly using vaccines and effective equipment. In Middle East & Africa, the development of additional expert MTB/RIF machines creates good scope for the market, which is also driven by the effectiveness of the national tuberculosis control program and the quality of the region’s laboratory infrastructure.

Sanofi Aventis, Aventis Pharmaceutical Ltd., Novartis AG, and Bayer Healthcare are key players operating in the tuberculosis therapeutic market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Tuberculosis Therapeutic Market

Pre Book